Literature DB >> 7320631

Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.

J J Albers, C H Chen, J L Adolphson.   

Abstract

The relationship between plasma lecithin:cholesterol acyltransferase mass and enzyme activity and between mass and plasma cholesterol esterification rate was determined in 25 adult volunteers without overt disease (14 normolipidemic and 11 hyperlipidemic). Furthermore, the relationship of lecithin:cholesterol acyltransferase mass and cholesterol esterification rate to lipids, apoproteins, age, and ideal body weight was assessed. Lecithin:cholesterol acyltransferase mass determined by radioimmunoassay was highly correlated with enzyme activity assayed using a heated plasma substrate (r = 0.636) and with the molar cholesterol esterification rate determined either by radioassay (r = 0.809) or by measurement of the decrease of unesterified cholesterol (r = 0.621). Lecithin:cholesterol acyltransferase mass was also positively correlated with total cholesterol (r = 0.608), unesterified cholesterol (r = 0.562), age (r = 0.544), and percent ideal body weight (r = 0.619), but was not significantly correlated with log triglyceride, high density lipoprotein cholesterol, or apolipoproteins A-I, A-II, or D. Plasma cholesterol esterification rate by both methods was highly positively correlated with total cholesterol, unesterified cholesterol, log triglyceride, and age, but was inversely correlated with high density lipoprotein cholesterol. Upon partial correlation analysis with lecithin:cholesterol acyltransferase mass kept constant the cholesterol esterification rate remained significantly positively related to total cholesterol, unesterified cholesterol, and log triglyceride and inversely related to high density lipoprotein cholesterol. Two subjects had normal lecithin:cholesterol acyltransferase but approximately half normal molar cholesterol esterification rate. Measurement of lecithin:cholesterol acyltransferase mass and activity along with plasma cholesterol esterification rate will permit differentiation of abnormalities of enzyme from qualitative or quantitative substrate or cofactor abnormalities. Also, the finding that the regression line between LCAT mass and the plasma esterification rate by direct determination of unesterified cholesterol passes through the origin suggests that all immunodetectable LCAT in plasma is active in normal subjects.-Albers, J. J., C-H. Chen, and J. L. Adolphson. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320631

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

1.  Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.

Authors:  Eric Soupene; Mark S Borja; Mauricio Borda; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2016-06-27

2.  Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.

Authors:  Shigemasa Tani; Atsuhiko Takahashi; Ken Nagao; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2015-04-19       Impact factor: 2.037

3.  AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice.

Authors:  Zhu Chen; Donald Chu; Jose M Castro-Perez; Weihua Ni; Aiwu Zhang; Mihajlo L Krsmanovic; Dan Xie; Vinit Shah; Steven J Stout; David G McLaren; Alice C Stefanni; Sang Ho Lee; Thomas P Roddy; Andrew S Plump; Brian K Hubbard; Thomas F Vogt; Heather H Zhou
Journal:  J Cardiovasc Transl Res       Date:  2011-08-06       Impact factor: 4.132

4.  A high cholesterol/cholate diet induced fatty liver in spontaneously hypertensive rats.

Authors:  K Ueno; H Okuyama
Journal:  Lipids       Date:  1986-08       Impact factor: 1.880

5.  A 31P nuclear magnetic resonance investigation of acyl group transfer from phosphatidylcholine to yield lysophosphatidylcholine in human plasma.

Authors:  M H Nouri-Sorkhabi; D R Sullivan; D C Roberts; P W Kuchel
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

6.  Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men.

Authors:  P T Williams; J J Albers; R M Krauss; P D Wood
Journal:  Atherosclerosis       Date:  1990-05       Impact factor: 5.162

7.  Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.

Authors:  M E Brousseau; S Santamarina-Fojo; L A Zech; A M Bérard; B L Vaisman; S M Meyn; D Powell; H B Brewer; J M Hoeg
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

8.  Hypertension in rats does not potentiate hypercholesterolemia and aortic cholesterol deposition induced by a hypercholesterolemic diet.

Authors:  H Mori; K Ishiguro; H Okuyama
Journal:  Lipids       Date:  1993-02       Impact factor: 1.880

9.  Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study.

Authors:  A G Holleboom; J A Kuivenhoven; M Vergeer; G K Hovingh; J N van Miert; N J Wareham; J J P Kastelein; K-T Khaw; S M Boekholdt
Journal:  J Lipid Res       Date:  2009-08-11       Impact factor: 5.922

10.  Decreased lecithin:cholesterol acyltransferase activity in the plasma of hypercholesterolemic pigs.

Authors:  A G Lacko; S M Lee; I Mirshahi; J Hasler-Rapacz; B J Kudchodkar; J Rapacz
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.